Tan et al., 2019 - Google Patents
Self‐reactivity on a spectrum: a sliding scale of peripheral B cell toleranceTan et al., 2019
View PDF- Document ID
- 3301774379236643447
- Author
- Tan C
- Noviski M
- Huizar J
- Zikherman J
- Publication year
- Publication venue
- Immunological reviews
External Links
Snippet
Efficient mechanisms of central tolerance, including receptor editing and deletion, prevent highly self‐reactive B cell receptors (BCRs) from populating the periphery. Despite this, modest self‐reactivity persists in (and may even be actively selected into) the mature B cell …
- 230000002093 peripheral 0 title abstract description 25
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tan et al. | Self‐reactivity on a spectrum: a sliding scale of peripheral B cell tolerance | |
| Noviski et al. | IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate | |
| Bour‐Jordan et al. | Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells | |
| Yarkoni et al. | Molecular underpinning of B‐cell anergy | |
| Bour‐Jordan et al. | Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/B7 family | |
| Balagopalan et al. | The LAT story: a tale of cooperativity, coordination, and choreography | |
| Sansom et al. | The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology | |
| Mugnier et al. | Coronin-1A links cytoskeleton dynamics to TCRαβ-induced cell signaling | |
| Tan et al. | Nur77 links chronic antigen stimulation to B cell tolerance by restricting the survival of self-reactive B cells in the periphery | |
| Fernández‐Arenas et al. | β‐arrestin‐1 mediates the TCR‐triggered re‐routing of distal receptors to the immunological synapse by a PKC‐mediated mechanism | |
| Nair‐Gill et al. | Calcium flux control by Pacs1‐Wdr37 promotes lymphocyte quiescence and lymphoproliferative diseases | |
| Hiwa et al. | NR4A nuclear receptors in T and B lymphocytes: Gatekeepers of immune tolerance | |
| Cheng et al. | Themis2 lowers the threshold for B cell activation during positive selection | |
| Getahun | Role of inhibitory signaling in peripheral B cell tolerance | |
| Borde et al. | Transcriptional basis of lymphocyte tolerance | |
| Pandey et al. | The autoimmune disorder susceptibility gene CLEC16A restrains NK cell function in YTS NK cell line and Clec16a knockout mice | |
| Wang et al. | Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells | |
| McCaleb | Regulation of Central B Cell Tolerance by CD19 and Foxo1Expression | |
| WO2006074370A2 (en) | Agonists and antagonists of tnfrii/cd120b for treatment of immune-related diseases | |
| Haribhai et al. | Functional reprogramming of the primary immune response by T cell receptor antagonism | |
| Yabas et al. | ATP11c is critical for phosphatidylserine internalization and B lymphocyte differentiation | |
| Tan | Negative regulation of B cell responses by Nur77 (Nr4a1) | |
| Aschenbrenner et al. | OPEN ACCESS EDITED BY | |
| Wilson et al. | B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes | |
| Masubuchi et al. | Evolutionary fingerprint in rodent PD1 confers weakened activity and enhanced tumor immunity compared to human PD1 |